Magnetic resonance-assessed lipoprotein profile. The time has come for its clinical use

Author(s):  
Lluís Masana ◽  
Daiana Ibarretxe
2020 ◽  
pp. 69-93
Author(s):  
Jing Guo ◽  
Ingolf Sack ◽  
Stephan Rodrigo Marticorena Garcia

2019 ◽  
Vol 2019 ◽  
pp. 1-10
Author(s):  
Ryo Sakamoto ◽  
Christopher Marano ◽  
Michael I. Miller ◽  
Constantine G. Lyketsos ◽  
Yue Li ◽  
...  

For patients with cognitive disorders and dementia, accurate prognosis of cognitive worsening is critical to their ability to prepare for the future, in collaboration with health-care providers. Despite multiple efforts to apply computational brain magnetic resonance image (MRI) analysis in predicting cognitive worsening, with several successes, brain MRI is not routinely quantified in clinical settings to guide prognosis and clinical decision-making. To encourage the clinical use of a cutting-edge image segmentation method, we developed a prediction model as part of an established web-based cloud platform, MRICloud. The model was built in a training dataset from Alzheimer’s Disease Neuroimaging Initiative (ADNI) where baseline MRI scans were combined with clinical data over time. Each MRI was parcellated into 265 anatomical units based on the MRICloud fully automated image segmentation function, to measure the volume of each parcel. The Mini Mental State Examination (MMSE) was used as a measure of cognitive function. The normalized volume of 265 parcels, combined with baseline MMSE score, age, and sex were input variables for a Least Absolute Shrinkage and Selection Operator (LASSO) regression analysis, with MMSE change in the subsequent two years as the target for prediction. A leave-one-out analysis performed on the training dataset estimated a correlation coefficient of 0.64 between true and predicted MMSE change. A receiver operating characteristic (ROC) analysis estimated a sensitivity of 0.88 and a specificity of 0.76 in predicting substantial cognitive worsening after two years, defined as MMSE decline of ≥4 points. This MRICloud prediction model was then applied to a test dataset of clinically acquired MRIs from the Johns Hopkins Memory and Alzheimer’s Treatment Center (MATC), a clinical care setting. In the latter setting, the model had both sensitivity and specificity of 1.0 in predicting substantial cognitive worsening. While the MRICloud prediction model demonstrated promise as a platform on which computational MRI findings can easily be extended to clinical use, further study with a larger number of patients is needed for validation.


Thyroid ◽  
1999 ◽  
Vol 9 (6) ◽  
pp. 591-597 ◽  
Author(s):  
MARIE-ELISABETH TOUBERT ◽  
FRANÇOISE CYNA-GORSE ◽  
ANNE-MARIE ZAGDANSKI ◽  
SOPHIE NOEL-WEKSTEIN ◽  
PIERRE CATTAN ◽  
...  

2005 ◽  
Vol 51 (8) ◽  
pp. 1457-1461 ◽  
Author(s):  
Martin Petersen ◽  
Marianne Dyrby ◽  
Søren Toubro ◽  
Søren Balling Engelsen ◽  
Lars Nørgaard ◽  
...  

Abstract Background: Cardiovascular disease risk can be estimated in part on the basis of the plasma lipoprotein profile. Analysis of lipoprotein subclasses improves the risk evaluation, but the traditional methods are very time-consuming. Novel, rapid, and productive methods are therefore needed. Methods: We obtained plasma samples from 103 fasting people and determined the plasma lipoprotein subclass profiles by an established ultracentrifugation-based method. Proton nuclear magnetic resonance (NMR) spectra were obtained from replicate samples on a 600 MHz NMR spectrometer. From the ultracentrifugation-based reference data and the NMR spectra, we developed partial least-squares (PLS) regression models to predict cholesterol and triglyceride (TG) concentrations in plasma as well as in VLDL, intermediate-density lipoprotein (IDL), LDL, 3 LDL fractions, HDL, and 3 HDL subclasses. Results: The correlation coefficients (r) between the plasma TG and cholesterol concentrations measured by the 2 methods were 0.98 and 0.91, respectively. For LDL- and HDL-cholesterol concentrations, r = 0.90 and 0.94, respectively. For cholesterol concentrations in the LDL-1, LDL-2, and LDL-3 fractions, r = 0.74, 0.78, and 0.69, respectively, and for HDL subclasses HDL2b, HDL2a, and HDL3, cholesterol concentrations were predicted with r = 0.92, 0.94, and 0.75, respectively. TG concentrations in VLDL, IDL, LDL, and HDL were predicted with correlations of 0.98, 0.85, 0.77, and 0.74, respectively. The cholesterol and TG concentrations in the main lipoprotein fractions and in LDL fractions and HDL subclasses predicted by the PLS models were 94%–100% of the concentrations obtained by ultracentrifugation. Conclusion: NMR-based PLS regression models are appropriate for use in research in which analyses of the plasma lipoprotein profile, including LDL and HDL subclasses, are required in large numbers of samples.


1982 ◽  
Vol 1 (3) ◽  
pp. 184
Author(s):  
R.H.T. Edwards ◽  
M.Joan Dawson ◽  
D.R. Wilkie ◽  
R. Gordon ◽  
D. Shaw

Sign in / Sign up

Export Citation Format

Share Document